Abbott GmbH & Co. KG
Records under this name other than patents Abbott GmbH & Co. KG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,202,870 | Substituted oxindole derivatives, medicaments containing the latter and use thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,436,149 | Crystalline Anti-Htnfalpha Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 8,772,458 | Crystalline Anti-Htnfalpha Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 8,383,641 | Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,263,558 | Methods of Preparation of Recombinant Forms of Human Beta-Amyloid Protein and Uses of These Proteins Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 8,906,864 | Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,623,819 | Therapy for Complications of Diabetes Formerly held In force · High confidence | In force | High confidence | |
| US 8,497,072 | Amyloid-Beta Globulomer Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 8,486,456 | Itraconazole compositions with improved bioavailability Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,895,004 | Method for the treatment of amyloidoses Formerly held In force · USPTO record | In force | USPTO record |